Potentiation by cholinesterase inhibitors of cholinergic activity in rat isolated stomach and colon

Pharmacological Research

Volumn 58, Issue 5-6, 2008, Pages 297-301

  Jarvie, Emma M ^a   Cellek, Selim ^a   Sanger, Gareth J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cholinesterase; Donepezil; Gastric motility; Itopride; Neostigmine; Tegaserod

Indexed keywords

8 AMINO 7 CHLORO 1,4 BENZODIOXAN 5 CARBOXYLIC ACID 1 BUTYL 4 PIPERIDINYLMETHYL ESTER; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; ISO OMPA; ITOPRIDE; NEOSTIGMINE; PROKINETIC AGENT; SEROTONIN 4 AGONIST; SEROTONIN 4 ANTAGONIST; TEGASEROD;

ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CHOLINESTERASE INHIBITION; COLON; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; MALE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STOMACH MOTILITY;

ANIMALS; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; COLON; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; INDANS; INDOLES; MALE; NEOSTIGMINE; PARASYMPATHETIC NERVOUS SYSTEM; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; STOMACH; TETRAISOPROPYLPYROPHOSPHAMIDE;

EID: 56649109718     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.09.001     Document Type: Article

References (24)

1. Appleyard M.E., and Smith A.D. Secretion of acetylcholinesterase and butyrylcholinesterase from the guinea-pig isolated ileum. Br J Pharmacol 97 (1989) 490-498
2. Ponec T.J., Saunders M.D., and Kimmey M.B. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 341 (1999) 137-141
3. Saunders M.D., and Kimmey M.B. Systematic review: acute colonic pseudo-obstruction. Aliment Pharmacol Ther 22 (2005) 917-925
4. Kreis M.E., Kasparek M., Zittel T.T., Becker H.D., and Jehle E.C. Neostigmine increases postoperative colonic motility in patients undergoing colorectal surgery. Surgery 130 (2001) 449-456
5. Rubiales A.S., Hernansanz S., Gutierrez C., Valle MLdel, and Flores L.A. Neostigmine for refractory constipation in advanced cancer patients. J Pain Symptom Manage 32 (2006) 204-205
6. Singal A.K., Rosman A.S., Bauman W.A., and Korsten M.A. Recent concepts in the management of bowel problems after spinal cord injury. Adv Med Sci 51 (2006) 15-22
7. Imbimbo B.P. Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease. CNS Drugs 15 (2001) 375-390
8. Thomas M.C., and Erstad B.L. Safety of enteral naloxone and i.v. neostigmine when used to relieve constipation. Am J Health Syst Pharm 60 (2003) 1264-1267
9. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochr Database Syst Rev 1 (2006) CD005593
10. Iwanaga Y., Kimura T., Miyashita N., Morikawa K., Nagata O., Itoh Z., et al. Characterization of acetylcholinesterase-inhibition by itopride. Jpn J Pharmacol 66 (1994) 317-322
11. Iwanaga Y., Miyashita N., Saito T., Morikawa K., and Itoh Z. Gastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogs. Jpn J Pharmacol 71 (1996) 129-137
12. Sawant P., Das H.S., Desai N., Kalokhe S., and Patil S. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia. J Assoc Phys India 52 (2004) 626-628
13. Holtmann G., Talley N.J., Liebregts T., Adam B., and Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 354 (2006) 832-840
14. Bassil A., Dass N.M., and Sanger G.J. The gastric prokinetic-like activity of ghrelin in rat isolated stomach is mediated via cholinergic and tachykininergic motor neurones. Eur J Pharmacol 544 (2006) 146-152
15. Bolton V., Bassil A.K., Lee K., and Sanger G.J. Inhibition by tianeptine of neuronally mediated contractions in the rat isolated gastrointestinal tract. Pharmacol Res 57 (2008) 339-343
16. Liston D.R., Nielsen J.A., Villalobos A., Chapin D., Jones S.B., Hubbard S.T., et al. Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease. Eur J Pharmacol 486 (2004) 9-17
17. 4 receptor antagonist, on guinea-pig distal colon. Br J Pharmacol 112 (1994) 789-794
18. 4 receptor activation facilitates recovery from synaptic rundown and increases transmitter release from single varicosities of myenteric neurons. Am J Physiol 294 (2008) G1376-G1383
19. Austin L., and Berry W.K. Two selective inhibitors of cholinesterase. Biochem J 54 (1953) 695-700
20. Sugimoto H., Ogura H., Arai Y., Iimura Y., and Yamanishi Y. Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor. Jpn J Pharmacol 89 (2002) 7-20
21. Sine J.P., Toutant J.P., Weigel P., and Colas B. Amphiphilic forms of butyrylcholinesterase in mucosal cells of rat intestine. Biochemistry 31 (1992) 10893-10900
22. Hecker S.E., and Mitchelson F. The effect of cholinesterase inhibitors on the antimuscarinic effect of hemicholinium-3 (HC-3) in the rat. J Pharm Pharmacol 28 (1976) 441-446
23. Atack J.R., Yu Q.S., Soncrant T.T., Brossi A., and Rapoport S.I. Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases. J Pharmacol Exp Ther 249 (1989) 194-202
24. Inglis F. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. Int J Clin Pract Suppl 127 (2002) 45-63